Get the app
US › Healthcare

ICON PLC (ICLR)

US · Healthcare · Diagnostics & Research

$170.18-2.83%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$2.06B
Revenue YoY
+2.3%
Net profit
$72.6M
Profit YoY
-60.3%
EPS
$2.35
EPS estimate
$2.26
Net margin
3.5%

EPS came in at 2.35 against a street estimate of 2.26 — a beat of 4.0%.

Key statistics

Market cap
$13.13B
P/E
179.1
Forward P/E
14.7
P/B
1.35
Book value
$121.55
EPS (TTM)
$0.95
52-week high
$203.91
52-week low
$66.57
50-day MA
$167.39
200-day MA
$145.73
Beta
1.24

Analyst view

Analysts rate ICON PLC a buy (10 buy, 8 hold, 0 sell out of 18) with an average price target of $187.76.

From the latest earnings call · 2026-07-30

MIXED ICON posted solid Q2 with 1.51x net book-to-bill driven by strong $3.7B bookings, but elevated pass-throughs pressured margins to 15.9%. Management reaffirmed FY26 guidance despite mix headwinds; AI partnerships with Anthropic and Microsoft aim to drive future productivity. Q2 2026 China emerging as notable growth driver with improved biotech partnerships; U.S. seeing elevated trial costs from healthcare inflation and high site demand. Analysts pressed on pass-through magnitude, large pharma demand, and SG&A sustainability. Management guided conservatively, avoided pinpoint numbers, and emphasized EBITDA dollar focus over margin %; acknowledged H2 cost actions and mix normalization will drive progression. 2026-07-30…

Full summary in the app.

Shareholding

Insiders
0.45%
Institutions
107.83%

Largest institutional holders

FundStake
Artisan Partners Limited Partnership11.19%
Wellington Management Company LLP6.90%
FMR Inc6.83%
Amvescap Plc.6.82%
Harris Associates L.P.5.79%
Brave Warrior Advisors LLC4.09%
Greenhaven Associates Inc4.02%
Principal Financial Group Inc3.82%

Recent filings & reports

DocumentDate
Current report (6-K) · Q4 2026
OTHER NOTABLE POINTS • ICON plc filed a Form 6-K with the U.S. Securities and Exchange Commission for October 2026. • The filing announces that ICON
2026-10-08
Current report (6-K) · Q3 2026
HEADLINE NUMBERS • ICON plc filed a Form 6-K with the SEC for September 2026. • The filing contains unaudited non-consolidated non-statutory interim
2026-09-09
Current report (6-K) · Q3 2026
HEADLINE NUMBERS • ICON plc filed a Form 6-K for August 2026. • The filing announces the release of ICON’s 2025 ICON Cares Report. • The report cov
2026-08-20
Current report (6-K) · Q3 2026
HEADLINE NUMBERS • ICON Investments Six Designated Activity Company established three senior note series on August 13, 2026. • The notes carry fixed
2026-08-18
Current report (6-K) · Q3 2026
HEADLINE NUMBERS • ICON announced pricing of USD 2.15 billion of notes. • The notes are being issued through a private offering. • The filing is da
2026-08-06
Annual report FY2025 (20-F)
HEADLINE NUMBERS • ICON’s fiscal year ended December 31, 2025 filing includes a major restatement of previously reported 2023 and 2024 financial stat
2026-05-27
Annual report FY2024 (20-F)2025-02-21
Annual report FY2023 (20-F)2024-02-23

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ICON PLC — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-19.